BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 28039784)

  • 1. Verteporfin based silica nanoparticle for in vitro selective inhibition of human highly invasive melanoma cell proliferation.
    Rizzi M; Tonello S; Estevão BM; Gianotti E; Marchese L; Renò F
    J Photochem Photobiol B; 2017 Feb; 167():1-6. PubMed ID: 28039784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Molecule-Targeted Therapy and Photodynamic Therapy Using Nanoformulated Verteporfin for Effective Uveal Melanoma Treatment.
    Song M; Zhu L; Zhang L; Ge X; Cao J; Teng Y; Tian R
    Mol Pharm; 2024 May; 21(5):2340-2350. PubMed ID: 38546166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review.
    Nkune NW; Abrahamse H
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Toxicity of Gas Plasma Treatment and Nanoparticles Exposure in Melanoma Cells In Vitro.
    Bekeschus S
    Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33809825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low concentrations of neutrophil extracellular traps induce proliferation in human keratinocytes via NF-kB activation.
    Tonello S; Rizzi M; Migliario M; Rocchetti V; Renò F
    J Dermatol Sci; 2017 Oct; 88(1):110-116. PubMed ID: 28576417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in nanomaterial-based drug delivery systems for melanoma therapy.
    Parhi R; Kaishap PP; Jena GK
    ADMET DMPK; 2024; 12(1):107-150. PubMed ID: 38560710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photosensitizers-Loaded Nanocarriers for Enhancement of Photodynamic Therapy in Melanoma Treatment.
    Udrea AM; Smarandache A; Dinache A; Mares C; Nistorescu S; Avram S; Staicu A
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the role of Yes-associated protein in dermatosis.
    Jia X; He L; Yang Z
    Skin Res Technol; 2023 Mar; 29(3):e13285. PubMed ID: 36973973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery.
    Kolimi P; Narala S; Youssef AAA; Nyavanandi D; Dudhipala N
    Nanotheranostics; 2023; 7(1):70-89. PubMed ID: 36593800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the Application of Nanomaterials to the Treatment of Melanoma.
    Wang Z; Yu Y; Wang C; Li J; Pang Y
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red Upconverter Nanocrystals Functionalized with Verteporfin for Photodynamic Therapy Triggered by Upconversion.
    Miletto I; Gionco C; Paganini MC; Cerrato E; Marchese L; Gianotti E
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verteporfin-Loaded Mesoporous Silica Nanoparticles' Topical Applications Inhibit Mouse Melanoma Lymphangiogenesis and Micrometastasis In Vivo.
    Clemente N; Miletto I; Gianotti E; Sabbatini M; Invernizzi M; Marchese L; Dianzani U; Renò F
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous Silica Nanoparticles Functionalized with Amino Groups for Biomedical Applications.
    Estevão BM; Miletto I; Hioka N; Marchese L; Gianotti E
    ChemistryOpen; 2021 Dec; 10(12):1251-1259. PubMed ID: 34907672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape.
    Battaglia L; Scomparin A; Dianzani C; Milla P; Muntoni E; Arpicco S; Cavalli R
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment.
    Yu Z; Gao L; Chen K; Zhang W; Zhang Q; Li Q; Hu K
    Nanoscale Res Lett; 2021 May; 16(1):88. PubMed ID: 34014432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Temperature Argon Plasma Regulates Skin Moisturizing and Melanogenesis-Regulating Markers through Yes-Associated Protein.
    Kim HY; Agrahari G; Lee MJ; Tak LJ; Ham WK; Kim TY
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor.
    Wei C; Li X
    Front Pharmacol; 2020; 11():557429. PubMed ID: 33178014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo.
    Michy T; Massias T; Bernard C; Vanwonterghem L; Henry M; Guidetti M; Royal G; Coll JL; Texier I; Josserand V; Hurbin AA
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31717427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous silica-based nanoplatforms for the delivery of photodynamic therapy agents.
    Hong SH; Choi Y
    J Pharm Investig; 2018; 48(1):3-17. PubMed ID: 30546918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic Therapy for Metastatic Melanoma Treatment: A Review.
    Naidoo C; Kruger CA; Abrahamse H
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818791795. PubMed ID: 30099929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.